Celldex Therapeutics reported $2.62M in Debt for its fiscal quarter ending in September of 2025.





Debt Change Date
AbbVie USD 1000K 70.48B Sep/2025
Amgen USD 54.59B 1.62B Sep/2025
Bristol-Myers Squibb USD 50.93B 1.22B Jun/2025
Celldex Therapeutics USD 2.62M 410K Sep/2025
Glaxosmithkline GBP 17.75B 396M Sep/2025
Pfizer USD 60.85B 78M Sep/2025
Roche Holding CHF 33.03B 1.41B Jun/2025